StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Valeant Pharma (VRX) Resumes Free-Fall; Down 15%
October 22, 2015 9:44 AM
Valeant Pharma (NYSE: VRX) is back ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Trader Talk
Next Articles
Citron Research to Discuss Valeant Pharma (VRX) at 12:30PM on Bloomberg
October 22, 2015 10:45 AM
Deutsche Bank 'Remains Cautious' on Valeant (VRX); Analyst Maintains Hold Rating
October 22, 2015 9:37 AM
Pre-Open Stock Movers 10/22: (OCLR) (PFPT) (TXN) (MCD) Higher; (RLYP) (CYH) (APOL) (VRX) Lower (more...)
October 22, 2015 9:30 AM
Valeant's (VRX) Buy Rating Affirmed at BofA/Merrill Lynch
October 22, 2015 7:26 AM
BMO Capital Downgrades Valeant Pharmaceuticals (VRX) to Market Perform; Cannot Defend the Specialty Pharmacy Structure
October 22, 2015 7:00 AM
